학술논문
A Phase I Trial of CT900, a Novel a-Folate Receptor–Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer
Document Type
Article
Author
Banerjee, S.; Garces, A.I.; Michalarea, V.; Ang, J.E.; Biondo, A.; Ruddle, R.; Raynaud, F.; Riisnaes, R.; Gurel, B.; Tunariu, N.; Prout, T.; Parmar, M.; Zachariou, A.; Turner, A.; Minchom, A.; Lopez, J.; de Bono, J.; Banerji, U.; Funingana, I.-G.; Basu, B.; Little, M.; Cook, N.; Chua, S.; Porter, J.C.; Jenkins, B.; Hall, E.; McIntosh, S.; Ainscow, E.; Jones, R.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 1 November 2022, 28(21):4634-4641)
Subject
Language
English
ISSN
15573265
10780432
10780432